Pharma Outsourcing – Find the right partner
International annual partnering meeting PHARMA OUTSOURCING is targeted at R&D and CMC professionals, service providers and Invemstment Managers to meet, network and discuss best practices related to outsourcing in drug development. The event is organized for the second year and will cover all stages from preclinical research to late clinical phases as well as contract manufacturing and will feature 35 exhibitors and about 180 delegates. The day will be covered by the press.
Pharma Outsourcing 2016 will be moderated Sara Malcus, CEO at Metabogen in Gothenburg. One of the key items of the agenda is the interactive panel discussion moderated by Lucy Robertshaw, International Business Consultant at Lucy J Robertshaw that will allow you to submit questions and comments to decision makers other key stakeholders.
When: 8 december, 2016
Where: Stockholm Waterfront Congress Centre
Please register before December 8 →
If you are a service-provider or a distributor and want to register/book please mail to email@example.com
Our partnering meeting system will be available soon. Please make sure to register as a delegate now!
8:30 Registration, networking ant the exhibition and partnering meetings
9:00 Welcome and introduction Boel Jönsson, Kemivärlden Biotech Kemisk Tidskrift,/Journal of Chemistry & Biotechnology
9:05 The changing role of CRO’s in Innovation and Drug Development. Margareta Wissenbach, Aptuit
9:25 When and what to outsource or not. Lars Hedbys, Idogen
09:50 Overcoming Solubility Challenges in Early-Stage Development for Solid Dose Products. Kaspar van den Dries, Patheon Pharmaceuticals
10:35 -11:05 Coffee, networking at the exhibition and partnering meetings
11:05 Compliance and missing data – what should we think about?
Anna Bertland, Director of Data Management and Biostatistics, TFS
Anders Nordlund, Principal Biostatistician, TFS
11:25 Successful outsourcing is a key discipline in itself. Anna Törner, SDS
11:45 Manufacture of biopharmaceutical microbiome modulators. Peter Boman, Cobra Biologics
12.05 Lunch, networking at the exhibition and partnering meetings
13:15 Edvince – a novel biotech company established by combining a strong academic research group with skilled CROs and CMOs held together by entrepreneurial drive. Sarah Fredriksson, Edvince AB.
13:40 Benefits and outsourcing options for bioinformatics in pharmaceutical R&D. Antti Ylipää, Genevia Technologies
14.00 Panel discussion: ”What is the future for our industry?
14:50 Coffee, networking at the exhibition and partnering meetings
15:20 How are you measuring your molecules? Rickard Wahlström, Q&Q Labs
15:40 Outsourcing development activities in a virtual company. Jan Alenfall, Follicum
15.50-16.00 Conclusion, Sara Malcus, Metabogen
16.00-17:15 End of show drinks and refreshments reception
PharmaOutsourcing includes a combination of partnering, presentations, exhibition and informal networking. These four core elements of the day run in parallel and ensure that the event is a lively, energetic day designed to impart new knowledge and build new networks.
PRESENTATIONS: Listen to small, middle sized pharma and biotech companies and Big Pharma and hear their stories, learn about their needs and the requirements for the service providers. Learn how others are approaching shared outsourcing challenges. The seminar part of PharmaOutsourcing 2015 will be located next to the exhibition and the seminar program consists of one track.
EXHIBITION: The central hub of the event, the exhibition provides a platform for partners and vendors to engage and discuss outsourcing opportunities. Partners and vendors will be able to utilize the partnering software to arrange stand meetings at PharmaOutsourcing 2015.
INFORMAL NETWORKING: We hope you will be able to join us for the end of show drinks and refreshments reception, which provides a great opportunity to network with fellow delegates. Combined with the extended lunch break and coffee breaks, delegates will have ample opportunities to touch base on a more informal basis.
ONE-ON-ONE MEETINGS: To the PharmaOutsourcing philosophy, one-on-one meetings between partners and vendors provide a great opportunity to initiate contact or touch base on existing projects. Partnering is facilitated by using our partnering software, which is available to all delegates 6 weeks prior to the PharmaOutsourcing event. Participation in partnering meetings is completely optional.
Interview with the Organizer
Why you should make business with the Swedish life science industry.
About the Organizer
Kemivärlden Biotech med Kemisk Tidskrift/Journal of Chemistry & Biotechnology is the leading magazine in the Nordics with a focus on Chemistry, Biotechnology and Life Science. We are a subscription-based glossy magazine published 8 times per year. Ever since the magazine was founded in 1887, our core values have been credibility and quality. The Journal of Chemistry & Biotechnology reaches the members of SwedenBIO, Swedish Chemical Society, SwedNanoTech and other important groups associated with the biotech and Life Science industry.
Late February every year we publish our magazine in English for an international audience. To read the e-version of the international issue of 2015 please click here.
For current news and more information see the website: www.kemivarldenbiotech.se. At the website you also find a calendar covering the most important seminars, trade fairs and events. Our collaboration with Medicon Valley Alliance and other international partners opens up for delegates from e.g. Denmark, Holland, UK, US, Germany and the Baltics at our events.
Maria Eriksson is the initiator and program director of PharmaOutsourcing. She holds a MSc in Medical Biology from Linköping University. Maria has a current position as Business Development Manager at Journal of Chemistry & Biotechnology (Kemivärlden Biotech). She has a background from the pharma industry and Karolinska Hospital where she served as a Research Engineer in the Fertility Unit.
Maria is also the initiator and program director of other international annual events such as Are We on Track?, The Future of Swedish & Danish Life Science in Lund, New Updates in Drug Formulation & Biovailability in Copenhagen, Bioscience – Research Through innovative Technologies in Uppsala and New Horizons in Bioprocessing in Stockholm.